General Information |
|
Product |
CD21 Antibody BIOTIN |
Description |
BIOTIN-Conjugated Complement Receptor Type 2 Antibody N-epitope |
Verified Applications |
ELISA, IHC, IP, WB |
Host |
Rabbit |
Species Cross Reactivity |
Human, Mouse Predicted: Rat |
Immunogen |
Synthetic peptide taken within amino acid region 650-700 on human Complement Receptor type 2 isoform X1 protein. |
Accession # |
NCBI: XP_011507508.1 |
|
|
Quantity |
100 µg |
Volume |
200 µl |
Concentration |
0.55-0.75 µg/µl in antibody stabilization buffer |
Form |
BIOTIN-Conjugated |
Clonality |
Polyclonal |
Determinant |
N-epitope |
Storage |
-20⁰C for long term storage |
|
|
DB |
1:10,000 |
ELISA |
1:10,000 |
Immunohistochemistry | 1:50-1:150 |
Immunoprecipitation |
1:150 |
Western Blot |
1:500 |
|
|
Uniprot # |
|
Overview |
Receptor for complement C3Dd, for the Epstein-Barr virus on human B-cells and T-cells and for HNRPU. Participates in B lymphocytes activation. |
Molecular Function |
Complement binding; DNA binding; Protein homodimerization activity |
Subcellular Location |
Membrane; Single-pass type I membrane protein |
Expression |
Mature B-lymphocytes, T-lymphocytes, pharyngeal epithelial cells, astrocytes and follicular dendritic cells of the spleen. |
Structure |
Interacts (via Sushi domain 1 and 2) with C3dg. |
Alternative Nomenclature |
C3DR antibody CD21 antibody CD21 antigen antibody Complement C3d receptor antibody Complement component (3d/Epstein Barr virus) receptor 2 antibody Complement component receptor 2 antibody Cr 2 antibody CR antibody CVID7 antibody EBV receptor antibody EBV-R antibody Epstein Barr virus receptor antibody EVBR antibody SLEB9 antibody |
Protein information supplied by UniProt
Product | Note | Status | Price | |
---|---|---|---|---|
|
P-CD21.101 | |||
|
CD21-101AP | |||
|
CD21.101-FITC | |||
|
PC-CD21 | |||
Display accessory details |
Select your currency:
(c) FabGennix International Inc.